BETALOC TABLET 100MG

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktīvā sastāvdaļa:

METOPROLOL TARTRATE

Pieejams no:

ASTRAZENECA SDN. BHD.

SNN (starptautisko nepatentēto nosaukumu):

METOPROLOL TARTRATE

Vienības iepakojumā:

100Tablet Tablets; 100 Tablet Tablets

Ražojis:

AstraZeneca Pharmaceutical Co. Ltd.

Produkta apraksts

1
Betaloc Tablet
Metoprolol tartrate
Composition
1 tablet contains : 50 and 100 mg metoprolol tartrate respectively.
For a complete list of excipients , see List of excipients .
Pharmaceutical form
Tablet .
50 mg tablet s: W hite , round with a diameter of 8 mm , bisected , marked A/BB . The score mark
is not intended to divide the tablet into two equal doses. It is only to facilitate swallowing .
100 mg tablet s: W hite , round with a diameter of 10 mm , bisected, mark ed A/ M E. The tablet
can be divided into two equal doses .
Therapeutic indication s
Hypertension : to reduce blood pressure and to reduce the risk of cardiovascular and coronary
mortality (including sudden death) , and morbidity.
Angina pectoris.
Disturbances of cardiac rhythm including especially supraventricular tachycardia.
Confirmed or suspected m yocardial infarction - prevention of cardiac death and reinfarction.
Functional heart disorders with palpitations.
Migraine prophylaxis .
Hyperthyroidism.
Posology and Method of Administration
Dosage should be adjusted individually to avoid bradycardia. The tablets should be taken on
an empty stomach. Concomitant intake of food increases the bioavailability of metoprolol
with 40 %. The following is valid as guidelines:
Hypertension
100 -200 mg daily divided on one or two occasions. The table ts should be taken in the morning
if once -daily dosage. In patients not responding to 200 mg, the dose could be combined with
other antihypertensive agents, preferably diuretics and calcium antagonists of the
dihydropyridine type, or increased.